ADAPTDX
Dead / Abandoned — Abandoned — no statement of use filed (as of 25 Oct 2021)
What this means for you
This application is over — abandoned 25 Oct 2021. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88344838
- Mark type
- Stylized text
- Filed
- 18 Mar 2019
- Published for opposition
- 28 Jan 2020
- Abandoned
- 25 Oct 2021
- Attorney of record
- Hoang-chi Truong
Goods and services
- Class 005 — Pharmaceuticals: Immunosequencing-based assay kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, for detection of cancer, autoimmune disease and infection; medical diagnostic assay kits comprised of medical diagnostic reagents and assays for detecting cancer, autoimmune disease and infection; the aforementioned goods not in the field of or for use in the field of ocular diagnostics or treatment, including ophthalmology and optometry, and not for use in providing sales, marketing, or consulting services, including direct to consumer sales, direct to consumer marketing, and providing consulting services, in the field of ocular diagnostics or treatment
- Class 042 — Scientific and technological services: Medical laboratory services; the aforementioned services not in the field of or for use in the field of ocular diagnostics or treatment, including ophthalmology and optometry, and not for use in providing sales, marketing, or consulting services, including direct to consumer sales, direct to consumer marketing, and providing consulting services, in the field of ocular diagnostics or treatment
- Class 044 — Medical, beauty and agricultural services: Providing medical diagnostic and prognostic testing for cancer, autoimmune disease and infection, and the analysis, evaluation, and reporting of those test results to help healthcare professionals determine a patient's clinical diagnosis, the effectiveness of patient treatments, and to revise future treatments accordingly; providing medical diagnostic and prognostic testing services; medical services; consulting services in the field of medical diagnostic testing; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; the aforementioned services not in the field of or for use in the field of ocular diagnostics or treatment, including ophthalmology and optometry, and not for use in providing sales, marketing, or consulting services, including direct to consumer sales, direct to consumer marketing, and providing consulting services, in the field of ocular diagnostics or treatment
Owner
- Adaptive Biotechnologies Corporation, Seattle, WA, US
- Adaptive Biotechnologies Corporation, Seattle, WA, US
Prosecution history
- 25 Oct 2021 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 25 Oct 2021 — ABANDONMENT - NO USE STATEMENT FILED
- 24 Mar 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 22 Mar 2021 — SOU EXTENSION 2 GRANTED
- 22 Mar 2021 — SOU EXTENSION 2 FILED
- 22 Mar 2021 — SOU TEAS EXTENSION RECEIVED
- 17 Sept 2020 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 15 Sept 2020 — SOU EXTENSION 1 GRANTED
- 15 Sept 2020 — SOU EXTENSION 1 FILED
- 15 Sept 2020 — SOU TEAS EXTENSION RECEIVED
- 24 Mar 2020 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 28 Jan 2020 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 28 Jan 2020 — PUBLISHED FOR OPPOSITION
- 08 Jan 2020 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 23 Dec 2019 — ASSIGNED TO LIE